Skip to main content
WuXi AppTec Co., Ltd. logo

WuXi AppTec Co., Ltd. — Investor Relations & Filings

Ticker · 2359 ISIN · CNE100003F19 LEI · 254900OEPQLZSPLN9175 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 1,741 across all filing types
Latest filing 2025-07-14 Transaction in Own Shar…
Country CN China
Listing HKEX 2359

About WuXi AppTec Co., Ltd.

http://www.wuxiapptec.com.cn

WuXi AppTec Co., Ltd. is a global Contract Research, Development, and Manufacturing Organization (CRDMO) dedicated to enabling the pharmaceutical and life sciences industries. The company provides an integrated, open-access capability and technology platform to accelerate the discovery, development, and manufacturing of innovative therapies. Core services encompass a broad portfolio of R&D solutions, including discovery biology (hit finding, oncology services), analytical testing, and clinical research services. Utilizing its end-to-end CRDMO model, which includes specialized platforms like WuXi STA for pharmaceutical development and manufacturing, WuXi AppTec partners with clients globally to advance new medicines from concept through commercialization.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Stock Exchange FF305 “Next Day Disclosure Return” reporting changes in issued shares and extensive details of share repurchases by the issuer. It discloses repurchase dates, number of shares, average prices, confirmation of compliance, and fulfils the regulatory requirement for reporting transactions in the company’s own shares. This corresponds to the “Transaction in Own Shares” category (Code: POS).
2025-07-14 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return filed under Hong Kong Main Board Rule 13.25A / GEM Rule 17.27A detailing the issuer’s changes in issued shares and treasury shares, including multiple on-market share repurchases by the company. It is a formal regulatory disclosure of the company buying back its own shares. This matches the definition for “Transaction in Own Shares” (Code: POS).
2025-07-11 English
POSITIVE PROFIT ALERT
Earnings Release Classification · 91% confidence The document is a regulatory announcement under the Shanghai and Hong Kong listing rules titled “Positive Profit Alert,” summarizing the Company’s estimated revenue, net profit and EPS for the six months ended June 30, 2025. It provides key financial highlights ahead of the full interim results publication. This fits the description of an initial earnings release (key highlights only), not the full interim report, and is therefore classified as an Earnings Release. H1 2025
2025-07-10 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 98% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing the company’s changes in issued shares and treasury shares, specifically its share repurchase programme implemented via on-market buybacks on the Shanghai Stock Exchange. It is neither an AGM materials deck nor an earnings/annual report, but a detailed record of the company’s own share transactions. This matches the “Transaction in Own Shares” category (share repurchase/issuance) under code POS.
2025-07-10 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Hong Kong Stock Exchange ‘Next Day Disclosure Return’ (Form FF305) detailing changes in issued shares, treasury shares and a series of A-share repurchases under listing rule 13.25A/10.06. It is a formal regulatory report of the company buying back its own shares. This falls squarely under Transaction in Own Shares (POS).
2025-07-09 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is a Next Day Disclosure Return (Form FF305) under the Hong Kong Listing Rules specifying changes in issued shares and detailed repurchase transactions of the company’s own A Shares. It cites Main Board Rule 13.25A/GEM Rule 17.27A and Rule 10.06(4)(a)/GEM Rule 13.13(1) and provides a full repurchase report (Section II) and confirmation. This is a report of the company buying back its own shares, fitting precisely the “Transaction in Own Shares” category.
2025-07-08 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.